tiprankstipranks
So-Young International (SY)
NASDAQ:SY
US Market
Want to see SY full AI Analyst Report?

So-Young International (SY) Earnings Dates, Call Summary & Reports

189 Followers

Earnings Data

Report Date
Aug 13, 2026
Before Open (Not Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.09
Last Year’s EPS
-0.07
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 22, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call communicated strong operational and top-line momentum driven by rapid expansion of the branded clinic network, substantial increases in aesthetic center revenue (+~186% YoY), improving clinic-level margins (27% gross margin, +8.4 pp YoY), rising treatment volumes and growing core membership. Management reinforced clinical, supply-chain and training investments and provided confident near-term guidance. Offsetting these positives are widened consolidated net losses, rising cost of revenue and elevated operating expenses tied to expansion, modest declines in non-clinic segments, and a slightly reduced cash balance after funding growth initiatives. On balance the substantive revenue and margin progress at the core clinic business and forward guidance materially outweigh near-term profitability and cash draws tied to scaling.
Company Guidance
Management guided Q2 aesthetic treatment service revenue of RMB 307–317 million (implying 112.6%–119.5% YoY growth) and reiterated a long‑term 1,000‑center goal, expecting new centers to ramp faster, per‑center revenue to keep climbing and a clear path to profitability as scale and efficiency improve; for context Q1 results and operating metrics included total revenue RMB 432.8M (+45.6% YoY), aesthetic center revenue RMB 282.4M (+185.8% YoY, >65% of total) with a ~27% gross margin (expanded +8.4 ppts YoY, +3.3 ppts QoQ), >148,000 verified treatment visits (+172% YoY), >325,000 verified treatments (+164% YoY), >310,000 active users (63,000+ Level‑3 members), 52% of new customers from referrals, 41 profitable centers and 48 centers with positive operating cash flow (net adds +15 and +9 QoQ), average mature‑center revenue ~RMB7.5M (growth centers ~RMB4.8M; ramp‑up ~RMB2.1M), cash and equivalents ~RMB880M (vs. RMB936.4M at year‑end 2025) and a net loss attributable of RMB49.2M (non‑GAAP loss RMB46.6M).
Strong Top-Line Growth
Total revenue for Q1 2026 was RMB 432.8–433 million, up ~45.6% year-over-year, driven by branded aesthetic center expansion and supply-chain momentum.
Aesthetic Center Revenue Surge
Revenue from aesthetic treatment services reached RMB 282.4 million, up ~185.8% year-over-year, accounting for over 65% of total revenue and marking the high end of guidance for the fourth consecutive quarter.
Rapid Treatment Volume and User Growth
Verified treatment visits exceeded 148,000 (up ~172% YoY) and verified treatments performed exceeded 325,000 (up ~164% YoY). Active user base grew to ~310,000 by March-end and Level 3+ core members exceeded 63,000.
Per-Center Economics and Scale Progress
As of quarter end management reported operating clinics between 54 and 59 (transcript variation); mature-phase centers generated ~RMB 150 million total (~RMB 7.5M per mature center), growth-phase ~RMB 109.5M (~RMB 4.8M per center) and ramp-up centers ~RMB 22.9M (~RMB 2.1M per center). Number of profitable centers rose to 41 and 48 centers generated positive operating cash flow.
Improving Margins at Clinic Business
Aesthetic center business gross margin reached 27%, with segment gross margin expanding by 8.4 percentage points year-over-year and 3.3 percentage points quarter-over-quarter, reflecting operating efficiency gains.
Product & Supply-Chain Wins (Blockbusters & Proprietary Products)
Revenue from blockbuster products contributed ~41% of Q1 revenue, with strong demand for BBL and thermage. Company launched new proprietary collagen and skin booster products via upstream partnerships (e.g., Jinbo Biopharmaceutical) and expanded its 'Green Label' compliant product system.
Operational & Clinical Capability Investments
Established a medical R&D and physician training center and a centralized safety/compliance control center; full-time physicians increased to ~230 (up ~9% from year-end 2025); physician-led consultation policy and digital diagnosis initiatives were deployed to improve quality and conversion.
Confident Near-Term Guidance
For Q2 2026 the company expects aesthetic treatment service revenues of RMB 307–317 million, implying year-over-year growth of ~112.6%–119.5% — signaling continued confidence in the branded clinic growth trajectory.

So-Young International (SY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 13, 2026
2026 (Q2)
-0.09 / -
-0.068
May 22, 2026
2026 (Q1)
-0.11 / -0.09
-0.062-50.00% (-0.03)
Mar 25, 2026
2025 (Q4)
-0.10 / -0.21
-1.13381.82% (+0.93)
Nov 17, 2025
2025 (Q3)
-0.05 / -0.12
0.038-419.23% (-0.16)
Aug 15, 2025
2025 (Q2)
-0.02 / -0.07
0.035-291.67% (-0.10)
May 16, 2025
2025 (Q1)
-0.05 / -0.06
-0.04-55.56% (-0.02)
Mar 28, 2025
2024 (Q4)
0.01 / -1.13
0.034-3447.83% (-1.17)
Nov 20, 2024
2024 (Q3)
<0.01 / 0.04
0.02180.56% (+0.02)
Aug 23, 2024
2024 (Q2)
0.03 / 0.04
-0.004900.00% (+0.04)
May 28, 2024
2024 (Q1)
>-0.01 / -0.04
-0.022-80.00% (-0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 22, 2026
$2.67$2.23-16.48%
Mar 25, 2026
$2.91$3.19+9.62%
Nov 17, 2025
$3.67$3.36-8.45%
Aug 15, 2025
$4.84$3.74-22.73%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does So-Young International (SY) report earnings?
So-Young International (SY) is schdueled to report earning on Aug 13, 2026, Before Open (Not Confirmed).
    What is So-Young International (SY) earnings time?
    So-Young International (SY) earnings time is at Aug 13, 2026, Before Open (Not Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SY EPS forecast?
          SY EPS forecast for the fiscal quarter 2026 (Q2) is -0.09.